Overcoming Clinical Trial Design Challenges in a Phase I/II Phase Myelodysplastic syndrome study
IDDI selected by a Sponsor as the full biometric partner including eClinical tools (EDC & RTSM), data collection, data cleaning…
Resources
Resources
Free Resources Library related to clinical trial innovation : Discover our recorded webinars, service flyers, experience, white papers and more related to clinical development.
SOCRATES (Standard of Care Randomized Trials) and the need for big randomized data.
April 26, 2021
IDDI Webinar on the SOCRATES (Standard of Care Randomized Trials) MODEL LEARN ON THE CHALLENGES AND OPPORTUNITIES OF THE STANDARD…
Designing a randomized trial with sample-size re-estimation: Challenges and Best Practices
LEARN ON SAMPLE-SIZE RE-ESTIMATION, CONDITIONAL POWER AND THE PROMISING-ZONE METHOD. In this webinar, we will play the part of a sponsor consulting…
Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice
IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies…
Bias and Randomization 1980 – 2020 – 2060
February 11, 2021
Learn on history of bias and randomization in oncology clinical trials and how to think about what constitutes persuasive evidence…
Demystifying Clinical Systems Integration
January 28, 2021
IDDI and XClinical webinar on the importance and the benefits Clinical Systems Integration WHAT YOU WILL LEARN:
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous…
Webinar: Clinical Trials for, and despite, COVID-19
October 27, 2020
IDDI Complimentary Webinar on characteristics of Covid-19 trials and impact of the pandemic on clinical trials The current SARS-CoV-2-induced…
Case study: The REALI pooled analysis of the European post-marketing studies for the TOUJEO® product
The purpose of the REALI pooled analysis is to advance the understanding of the effectiveness and real world safety of insulin Gla-300 based on a large European patient database of post-marketing interventional and observational studies.
Companion diagnostics and clinical development in oncology: a statistical perspective
September 17, 2020
IDDI Complimentary Webinar on the need for integration of biomarker and IVD validation in clinical development Drug development in many…